Growth Metrics

Novavax (NVAX) Acquisitions (2020)

Novavax has reported Acquisitions over the past 2 years, most recently at $1.3 million for Q4 2020.

  • Quarterly results put Acquisitions at $1.3 million for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2021 was $1.3 million (changed 0.0% YoY), and the annual figure for FY2020 was $165.5 million, changed.
  • Acquisitions for Q4 2020 was $1.3 million at Novavax, up from -$3.0 million in the prior quarter.
  • Over the last five years, Acquisitions for NVAX hit a ceiling of $1.3 million in Q4 2020 and a floor of $1.3 million in Q4 2020.